Company Filing History:
Years Active: 1989-1992
Title: Morris C. Berenbaum: Innovator in Cancer Treatment
Introduction
Morris C. Berenbaum is a notable inventor based in London, GB, recognized for his contributions to cancer treatment through innovative pharmaceuticals. With a total of three patents to his name, Berenbaum’s work focuses primarily on novel compounds that offer promising therapies for tumors.
Latest Patents
Berenbaum's latest patents include significant inventions centered around the use of porphyrins in cancer treatment. His first noteworthy invention, titled "Porphyrins and Cancer Treatment," details a unique method involving dihydro porphyrins and their tetra-hydro counterparts. This invention provides compounds that are administered to tumors, promoting necrosis when exposed to light of a specific wavelength absorbed by the compounds. The compounds are characterized by their chemical formula, where 'n' varies from 1 to 3 and substituents 'R' can be hydroxy groups at various positions in their respective phenyl rings.
Additionally, another related patent, "Dihydroporphyrins and Method of Treating Tumors," highlights an innovative approach to the same concept, reiterating the need for precise illumination post-administration to maximize therapeutic effects. This dual focus positions Berenbaum as an important figure in the realm of oncology drug development.
Career Highlights
Throughout his career, Morris C. Berenbaum has worked with prominent companies, including Efamol Holdings Plc and Efamol Limited. These positions have allowed him to not only refine his innovative ideas but also to implement them into practical applications aimed at improving patient outcomes.
Collaborations
Berenbaum has collaborated with several talented professionals in the field, including his coworker Raymond Bonnett. Together, they have contributed to advancing medical research, particularly in the areas pertaining to cancer therapies.
Conclusion
Morris C. Berenbaum stands out as a significant inventor whose work has the potential to impact cancer treatment significantly. With a focus on innovative compounds and treatment methods, his contributions are paving the way for future advancements in oncology. Through collaboration and a commitment to research, Berenbaum continues to be a vital player in the medical innovation landscape.